Annual securities reports (有価証券報告書) filed on EDINET — management narrative only (statistics tables, financial-statement notes, director remuneration and cross-shareholding disclosure are excluded). TSE corporate-governance reports and TDnet are separate documents and are not read here.
Noile-Immune Biotech Inc. 4893
| Cost of capital | no mention | matched by rule |
|---|---|---|
| PBR | no mention | matched by rule |
| Metric | names a metric 「(3)経営上の目標の達成状況を把握するための客観的な指標等当社は、現在研究開発段階にあり、売上高、利益率、ROA/ROEその他の数値的な目標となる経営指標等は用いておりません」BusinessPolicyBusinessEnvironmentIssuesToAddressEtcTextBlock | matched by rule |
| Target | no numeric target | matched by rule |
| Payout | policy language, no number 「これは、経営環境の変化に対応した機動的な資本政策の遂行及び株主還元策を可能とするためであります」OverviewOfCorporateGovernanceTextBlock | matched by rule |
For desks: your watchlist through these questions, kept current each filing season. Custom, from $999+.
Reply with your names